Ultrasonographic and radiographic evidence of attenuated joint destruction in early RA patients treated with infliximab

Eitemau Tebyg

• JOINT DESTRUCTION IS ATTENUATED BY INFLIXIMAB IN EARLY RA PATIENTS WITH ULTRASONOGRAPHIC MARKERS OF POOR PROGNOSIS
  gan: Taylor, P, et al.
  Cyhoeddwyd: (2003)
• Infliximab attenuates joint destruction in early RA patients with ultrasonographic markers of poor prognosis.
  gan: Taylor, P, et al.
  Cyhoeddwyd: (2002)
• Ultrasonographic evidence of attenuated joint destruction within 18 weeks in early RA patients treated with infliximab.
  gan: Taylor, P, et al.
  Cyhoeddwyd: (2003)
• Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis.
  gan: Taylor, P, et al.
  Cyhoeddwyd: (2004)
• Comparison of ultrasonographic measures of synovitis and radiographic assessment of structural damage over two years in a randomised, controlled trial of infliximab therapy in erosive early rheumatoid arthritis.
  gan: Taylor, P, et al.
  Cyhoeddwyd: (2004)